Subcutaneous NTG for US Radial Artery Cannulation (NTG-US-art)

AlRefaey Kandeel

Status: Completed

Conditions: Morbid Obesity

Treatments: Drug: Subcutaneous saline; Drug: Subcutaneous nitroglycrin

Study type: Interventional

Funder types: Other

Identifiers

NCT03006640

Refa-NTG-art

Details and patient eligibility

About

Clinicians are increasingly dealing with morbid obese patients. In morbid obese patients, difficult sampling and problems encountered with noninvasive blood pressure monitoring makes arterial cannulation an essential skill in many situations like surgeries or trans-radial procedures for coronary or carotid interventions.

Radial artery has been preferred over other sites for arterial cannulation due to low incidence of bleeding, better hemostats, more comfort, and immediate ambulation. sm In this study, subcutaneous nitroglycerin will be used to facilitate radial artery cannulation aiming to decrease insertion time, increase success rate and decrease related complications

Enrollment: 60 patients

Sex: All

Ages: 20 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• morbid obese indicated for radial artery cannuulation

Exclusion criteria

• +ve allen test peripheral arterial disease refusal

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

60 participants in 2 patient groups, including a placebo group

Control group

Placebo Comparator group

Treatment:

Drug: Subcutaneous saline

NTG group

Active Comparator group

Treatment:

Drug: Subcutaneous nitroglycrin